Table 3 AUC (adjusted) values for differentiation of CD vs. non-IBD, UC vs. non-IBD, and CD vs. UC using a GB classifier with 5-fold cross-validation under MAR, MCAR, and MNAR mechanisms.
From: Imputation methods for serologic biomarkers in inflammatory bowel disease
Percentage | MAR | MCAR | MNAR | |||
|---|---|---|---|---|---|---|
CD vs. non-IBD | ||||||
5 | II (BR) | 0.859 | II (BR) | 0.861 | II (BR) | 0.855 |
10 | II (BR) | 0.849 | II (BR) | 0.854 | II (BR) | 0.843 |
15 | II (BR) | 0.841 | II (BR) | 0.848 | II (BR) | 0.832 |
20 | II (BR) | 0.834 | II (BR) | 0.840 | II (BR) | 0.825 |
25 | II (BR) | 0.827 | II (BR) | 0.833 | II (BR) | 0.817 |
30 | II (BR) | 0.821 | II (BR) | 0.825 | II (BR) | 0.814 |
35 | II (BR) | 0.813 | AE | 0.815 | AE | 0.806 |
40 | II (BR) | 0.804 | AE | 0.806 | AE | 0.804 |
Original data | 0.866 | |||||
UC vs. non-IBD | ||||||
5 | AE | 0.805 | AE | 0.804 | II (RF) | 0.804 |
10 | AE | 0.795 | AE | 0.795 | II (RF) | 0.782 |
15 | AE | 0.785 | AE | 0.785 | II (RF) | 0.770 |
20 | AE | 0.775 | AE | 0.775 | II (RF) | 0.759 |
25 | AE | 0.741 | AE | 0.763 | AE | 0.749 |
30 | AE | 0.719 | AE | 0.751 | AE | 0.738 |
35 | AE | 0.699 | AE | 0.738 | AE | 0.731 |
40 | II (BR) | 0.684 | AE | 0.724 | AE | 0.721 |
Original data | 0.816 | |||||
CD vs. UC | ||||||
5 | II (BR) | 0.821 | II (BR) | 0.821 | II (RF) | 0.821 |
10 | II (BR) | 0.819 | II (BR) | 0.818 | II (BR) | 0.813 |
15 | II (BR) | 0.816 | II (BR) | 0.815 | II (BR) | 0.807 |
20 | II (BR) | 0.814 | II (BR) | 0.811 | II (BR) | 0.803 |
25 | II (BR) | 0.812 | II (BR) | 0.806 | II (BR) | 0.798 |
30 | II (BR) | 0.809 | II (BR) | 0.800 | II (BR) | 0.793 |
35 | II (BR) | 0.806 | AE | 0.793 | II (BR) | 0.788 |
40 | II (BR) | 0.801 | AE | 0.787 | AE | 0.784 |
Original data | 0.823 | |||||